Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
DR Wang, XL Wu, YL Sun - Signal transduction and targeted therapy, 2022 - nature.com
Cancers are highly complex diseases that are characterized by not only the overgrowth of
malignant cells but also an altered immune response. The inhibition and reprogramming of …
malignant cells but also an altered immune response. The inhibition and reprogramming of …
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
H Yu, L Lin, Z Zhang, H Zhang, H Hu - Signal transduction and targeted …, 2020 - nature.com
NF-κB pathway consists of canonical and non-canonical pathways. The canonical NF-κB is
activated by various stimuli, transducing a quick but transient transcriptional activity, to …
activated by various stimuli, transducing a quick but transient transcriptional activity, to …
CRISPR activation and interference screens decode stimulation responses in primary human T cells
Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity,
immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine …
immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine …
HLA-independent T cell receptors for targeting tumors with low antigen density
Chimeric antigen receptors (CARs) are receptors for antigen that direct potent immune
responses. Tumor escape associated with low target antigen expression is emerging as one …
responses. Tumor escape associated with low target antigen expression is emerging as one …
[HTML][HTML] Liquid-liquid phase separation: Orchestrating cell signaling through time and space
Cell signaling is a complex process. The faithful transduction of information into specific
cellular actions depends on the synergistic effects of many regulatory molecules, nurtured by …
cellular actions depends on the synergistic effects of many regulatory molecules, nurtured by …
Structural basis of assembly of the human T cell receptor–CD3 complex
The αβ T cell receptor (TCR), in association with the CD3γε–CD3δε–CD3ζζ signalling
hexamer, is the primary determinant of T cell development and activation, and of immune …
hexamer, is the primary determinant of T cell development and activation, and of immune …
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
O Dufva, J Koski, P Maliniemi, A Ianevski… - Blood, The Journal …, 2020 - ashpublications.org
Chimeric antigen receptor (CAR) T-cell therapy has proven effective in relapsed and
refractory B-cell malignancies, but resistance and relapses still occur. Better understanding …
refractory B-cell malignancies, but resistance and relapses still occur. Better understanding …
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
Abstract High dose interleukin-2 (IL-2) is active against metastatic melanoma and renal cell
carcinoma, but treatment-associated toxicity and expansion of suppressive regulatory T cells …
carcinoma, but treatment-associated toxicity and expansion of suppressive regulatory T cells …
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Immune checkpoint blockade has shown unprecedented and durable clinical response in a
wide range of cancers. T cell immunoglobulin and mucin domain 3 (TIM3) is an inhibitory …
wide range of cancers. T cell immunoglobulin and mucin domain 3 (TIM3) is an inhibitory …
The immunopathogenesis of fibrosis in systemic sclerosis
M Brown, S O'Reilly - Clinical & Experimental Immunology, 2019 - academic.oup.com
Systemic sclerosis (SSc) is an idiopathic systemic autoimmune disease. It is characterized
by a triad of hallmarks: immune dysfunction, fibrosis and vasculopathy. Immune dysfunction …
by a triad of hallmarks: immune dysfunction, fibrosis and vasculopathy. Immune dysfunction …